Access Clinical Trials, Inc.
Nashville, Tennessee, United States
Health in Nashville, Tennessee
2201 Murphy Ave STE 212, Nashville, TN 37203
About Access Clinical Trials, Inc.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Access Clinical Trials, Inc.
During the past decade, Access Clinical Trials, Inc. conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 5 clinical trials were completed, i.e. on
average, 71.4% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Rufinamide Given as Adjunctive Therapy in Participants With Refractory Partial Seizures
2006-02-13
2009-05-20
Completed
356
Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen
2006-10-04
2016-04-12
Completed
24,081
Open-Label Extension Study of Rufinamide Given as Adjunctive Therapy in Patients With Refractory Partial Seizures
2007-03-15
2010-05-14
Terminated
286
Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs
2009-04-01
2013-05-01
Completed
193
Efficacy/Safety Study of Brisdelle™ (Formerly Known as Mesafem) in the Treatment of Vasomotor Symptoms (VMS)
2011-05-01
2012-02-01
Completed
614
A Multicenter, Randomized, Open-Label, Parallel-Group Trial to Compare the Efficacy and Safety of the Sufentanil NanoTab PCA System/15 mcg (Zalviso™)to Intravenous Patient-Controlled Analgesia With Morphine for the Treatment of Acute Post-Operative Pain
2012-04-01
2012-12-01
Completed
357
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Access Clinical Trials, Inc." #1 sponsor was "Emalex Biosciences Inc." with 3 trials, followed by "Eisai Inc." with 2 trials
sponsored, "Pfizer" with 2 trials sponsored, "Shire" with 2 trials sponsored and "AcelRx Pharmaceuticals, Inc."
with 2 trials sponsored. Other sponsors include 0 different institutions and
companies that sponsored additional 10 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Access Clinical Trials, Inc."
#1 collaborator was "Duke Clinical Research Institute" with 1 trials as a collaborator, "Norgine" with 1 trials as a collaborator, "Pfizer" with 1 trials as a collaborator and "The Cleveland Clinic" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 4 trials.
Clinical Trials Conditions at Access Clinical Trials, Inc.
According to Clinical.Site data, the most researched conditions in "Access Clinical Trials, Inc." are
"Attention Deficit Hyperactivity Disorder (ADHD)" (2 trials), "Acute Coronary Syndrome" (1 trials), "Acute Treatment of Migraine" (1 trials), "Arthritis, Rheumatoid" (1 trials) and "Epilepsy" (1 trials). Many other conditions were trialed in "Access Clinical Trials, Inc." in a lesser frequency.
Clinical Trials Intervention Types at Access Clinical Trials, Inc.
Most popular intervention types in "Access Clinical Trials, Inc." are "Drug" (15 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (4 trials), "Ecopipam" (2 trials), "Rufinamide" (2 trials), "SHP465" (2 trials) and "5% dextrose in water" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Access Clinical Trials, Inc.
The vast majority of trials in "Access Clinical Trials, Inc." are
14 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at Access Clinical Trials, Inc.
Currently, there are NaN active trials in "Access Clinical Trials, Inc.".
undefined are not yet recruiting,
3 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 9 completed trials in Access Clinical Trials, Inc.,
undefined suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Access Clinical Trials, Inc., 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 12 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".